PHIA Stock Overview
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for PHIA from our risk checks.
Koninklijke Philips N.V. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €19.20 |
52 Week High | €21.80 |
52 Week Low | €16.60 |
Beta | 0.78 |
1 Month Change | 4.92% |
3 Month Change | -7.69% |
1 Year Change | 6.69% |
3 Year Change | -56.59% |
5 Year Change | -45.86% |
Change since IPO | -61.86% |
Recent News & Updates
Recent updates
Shareholder Returns
PHIA | DE Medical Equipment | DE Market | |
---|---|---|---|
7D | 2.7% | 2.1% | 0.5% |
1Y | 6.7% | -8.4% | 1.3% |
Return vs Industry: PHIA exceeded the German Medical Equipment industry which returned -7.7% over the past year.
Return vs Market: PHIA exceeded the German Market which returned 2.3% over the past year.
Price Volatility
PHIA volatility | |
---|---|
PHIA Average Weekly Movement | 4.3% |
Medical Equipment Industry Average Movement | 4.7% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.2% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PHIA has not had significant price volatility in the past 3 months.
Volatility Over Time: PHIA's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1891 | 69,656 | Roy Jakobs | www.philips.com |
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Koninklijke Philips N.V. Fundamentals Summary
PHIA fundamental statistics | |
---|---|
Market cap | €17.46b |
Earnings (TTM) | -€456.00m |
Revenue (TTM) | €18.17b |
1.0x
P/S Ratio-38.3x
P/E RatioIs PHIA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PHIA income statement (TTM) | |
---|---|
Revenue | €18.17b |
Cost of Revenue | €10.72b |
Gross Profit | €7.45b |
Other Expenses | €7.90b |
Earnings | -€456.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 29, 2024
Earnings per share (EPS) | -0.50 |
Gross Margin | 40.99% |
Net Profit Margin | -2.51% |
Debt/Equity Ratio | 54.8% |
How did PHIA perform over the long term?
See historical performance and comparison